Literature DB >> 23482606

Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries.

Pasqualino Malandrino1, Gabriella Pellegriti, Marco Attard, Maria Antonia Violi, Carla Giordano, Laura Sciacca, Concetto Regalbuto, Sebastiano Squatrito, Riccardo Vigneri.   

Abstract

CONTEXT: Papillary thyroid microcarcinoma (PTMC) is an indolent neoplasia, often asymptomatic and discovered incidentally. Some PTMCs, however, exhibit a more aggressive behavior, frequently recur, and can even cause cancer-related death.
OBJECTIVE: The aim of this study was to evaluate the prevalence of PTMCs and the associated risk factors at presentation in 2 thyroid cancer registries from areas with different genetic and environmental characteristics. DESIGN AND PATIENTS: We conducted a retrospective, observational study of all incident cases of PTMCs recorded over a 5-year period in the Sicilian Regional Registry for Thyroid Cancer (SRRTC) and in the Surveillance Epidemiology and End Results (SEER) US registry.
SETTING: The study took place at an academic hospital.
RESULTS: The incidence of PTMCs was much higher in Sicily (1777 PTMC diagnosed in 2002-2006; age-standardized incidence rate for the world population [ASRw] = 5.8 per 100 000) than in the United States (14 423 PTMC in the period 2004-2008; ASRw = 2.9 per 100 000). Within the SRRTC, a significantly higher incidence was observed in the volcanic area (ASRw = 10.4 vs 4.6 in the rest of Sicily). In Sicily, the female to male ratio was higher, and PTMC patients were younger. In both registries, a significant inverse correlation was observed between age and tumor size. Young patients (≤45 y) exhibited a higher frequency of nodal metastases.
CONCLUSIONS: PTMC incidence is twice as high in Sicily compared with the United States, and within Sicily, the incidence is twice as high in the volcanic area. In young patients, PTMCs are larger at presentation and exhibit more risk factors. In both registries, more than 35% of PTMCs exhibited 2 or more risk factors, suggesting that they may require surgery and follow-up similar to that of larger carcinomas.

Entities:  

Mesh:

Year:  2013        PMID: 23482606     DOI: 10.1210/jc.2012-3728

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.

Authors:  Ning Qu; Ling Zhang; Dao-Zhe Lin; Qing-Hai Ji; Yong-Xue Zhu; Yu Wang
Journal:  Tumour Biol       Date:  2015-12-21

2.  Should patients with papillary microcarcinoma undergo radioiodine ablation?

Authors:  Leonard Wartofsky
Journal:  Endocrine       Date:  2013-07-02       Impact factor: 3.633

3.  A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer.

Authors:  Claudia Martinuzzi; Lorenza Pastorino; Virginia Andreotti; Anna Garuti; Michele Minuto; Roberto Fiocca; Giovanna Bianchi-Scarrà; Paola Ghiorzo; Federica Grillo; Luca Mastracci
Journal:  Endocrine       Date:  2015-08-22       Impact factor: 3.633

4.  Current management of papillary thyroid microcarcinoma in Canada.

Authors:  Mazin Merdad; Antoine Eskander; John De Almeida; Jeremy Freeman; Lorne Rotstein; Shereen Ezzat; Anna M Sawka; David P Goldstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-08-14

Review 5.  The role of surgery in the current management of differentiated thyroid cancer.

Authors:  Giovanni Conzo; Nicola Avenia; Giuseppe Bellastella; Giancarlo Candela; Annamaria de Bellis; Katherine Esposito; Daniela Pasquali; Andrea Polistena; Luigi Santini; Antonio Agostino Sinisi
Journal:  Endocrine       Date:  2014-04-10       Impact factor: 3.633

6.  How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings?

Authors:  Loredana Pagano; Chiara Mele; Debora Arpaia; Maria Teresa Samà; Marina Caputo; Serena Ippolito; Carmela Peirce; Flavia Prodam; Guido Valente; Giuseppe Ciancia; Gianluca Aimaretti; Bernadette Biondi
Journal:  Endocrine       Date:  2016-05-26       Impact factor: 3.633

7.  Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination.

Authors:  Pasqualino Malandrino; Marco Russo; Anna Ronchi; Claudio Minoia; Daniela Cataldo; Concetto Regalbuto; Carla Giordano; Marco Attard; Sebastiano Squatrito; Francesco Trimarchi; Riccardo Vigneri
Journal:  Endocrine       Date:  2015-10-05       Impact factor: 3.633

8.  Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis.

Authors:  M-J Hu; Q Zhang; L Liang; S-Y Wang; X-C Zheng; M-M Zhou; Y-W Yang; Q Zhong; F Huang
Journal:  J Endocrinol Invest       Date:  2018-02-20       Impact factor: 4.256

9.  Papillary thyroid microcarcinoma: an over-treated malignancy?

Authors:  Tracy S Wang; Paolo Goffredo; Julie Ann Sosa; Sanziana A Roman
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

10.  Should small papillary thyroid cancer be observed? A population-based study.

Authors:  Naris Nilubol; Electron Kebebew
Journal:  Cancer       Date:  2014-11-25       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.